Literature DB >> 2981338

A soluble transcription system derived from purified vaccinia virions.

F Golini, J R Kates.   

Abstract

A soluble extract from purified vaccinia virus particles has been developed which displays site-specific initiation of transcription on exogenous DNA templates that carry cloned vaccinia virus early gene sequences. Bacterial plasmid vectors with segments of a strongly expressed early region of the vaccinia virus genome were active templates, whether in supercoiled or linear, truncated forms. Correct initiation, corresponding to that found in vivo, was observed for all early genes tested. The involvement of other factors besides the viral RNA polymerase was demonstrated by the loss of specific initiation upon partial purification of the enzyme. Initiation activity was restored by reconstitution of the system with factors lacking polymerase activity. The soluble system retained properties of transcription characteristic of intact viral cores, including (i) similar relative rates of initiation of various genes, (ii) multiple requirement for ATP, (iii) methylation and polyadenylation of transcripts, and (iv) inhibition by a topoisomerase antagonist.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981338      PMCID: PMC255011     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA.

Authors:  C M Wei; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

2.  Formation of the guanylylated and methylated 5'-terminus of vaccinia virus mRNA.

Authors:  B Moss; A Gershowitz; C M Wei; R Boone
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

3.  Two nucleid acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus. Purification and characterization.

Authors:  E Paolette; H Rosemond-Hornbeak; B Moss
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

4.  Poxvirus DNA-dependent RNA polymerase.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

5.  Cell-free translation of early and late mRNAs selected by hybridization to cloned DNA fragments derived from the left 14 million to 72 million daltons of the vaccinia virus genome.

Authors:  H B Isle; S Venkatesan; B Moss
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

6.  In vitro transcription of the inverted terminal repetition of the vaccinia virus genome: correspondence of initiation and cap sites.

Authors:  S Venkatesan; B Moss
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

7.  DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.

Authors:  J L Manley; A Fire; A Cano; P A Sharp; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

8.  A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

Authors:  W R Bauer; E C Ressner; J Kates; J V Patzke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

9.  Modification of RNA by mRNA guanylyltransferase and mRNA (guanine-7-)methyltransferase from vaccinia virions.

Authors:  S A Martin; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

10.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

View more
  19 in total

1.  In vitro recognition of an orf virus early promoter in a vaccinia virus extract.

Authors:  J C Vos; A A Mercer; S B Fleming; A J Robinson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Orthopoxvirus gene expression in Xenopus laevis oocytes: a component of the virion is needed for late gene expression.

Authors:  R F Massung; R W Moyer
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription.

Authors:  S S Broyles; B Moss
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

5.  In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence.

Authors:  C F Wright; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.

Authors:  J L Rosel; P L Earl; J P Weir; B Moss
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Identification of factors specific for transcription of the late class of vaccinia virus genes.

Authors:  C F Wright; B Moss
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters.

Authors:  L Yuen; B Moss
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

9.  Ordered assembly of a functional preinitiation transcription complex, containing vaccinia virus early transcription factor and RNA polymerase, on an immobilized template.

Authors:  C J Baldick; M C Cassetti; N Harris; B Moss
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Homology between RNA polymerases of poxviruses, prokaryotes, and eukaryotes: nucleotide sequence and transcriptional analysis of vaccinia virus genes encoding 147-kDa and 22-kDa subunits.

Authors:  S S Broyles; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.